Venn Life Sciences (LON:VENN) Shares Pass Above Fifty Day Moving Average – Here’s Why

Venn Life Sciences Holdings PLC (LON:VENNGet Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.

Venn Life Sciences Stock Up 7.0 %

The company has a debt-to-equity ratio of 35.83, a quick ratio of 1.48 and a current ratio of 2.30. The firm has a market capitalization of £4.89 million and a P/E ratio of -2.14. The stock has a fifty day moving average price of GBX 6.85 and a two-hundred day moving average price of GBX 6.85.

About Venn Life Sciences

(Get Free Report)

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.

Featured Stories

Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.